Institutional Review Board Statement
The study was conducted following the Declaration of Helsinki. Ethical clearance was obtained from Bellberry Human Research Ethics Committee Australia (2021-09-1137), conforming to the CONSORT 2010 guidelines, and registered as a clinical trial with the Australian and New Zealand Clinical Trials Registry (ACTRN12621001441808p). Each study participant was informed about the objective and purpose of the study. Written informed consent was obtained from each selected study participant prior to data collection. Participants were informed that they had the right to continue or withdraw from the study at any time. The confidentiality of the information provided by the study participants was protected by making the data collection procedure anonymous, and all information of the study subjects was kept confidential.